Microbial Enumeration and Specified Organism Testing — USP <61>, USP <62>, USP <60>
Quantitative determination of microbial contamination for pharmaceutical drug products, medical devices, and raw materials. We design enumeration programs that recover organisms reliably, satisfy method suitability requirements, and generate data that holds up under regulatory scrutiny.
Microbial enumeration and specified organism testing is foundational to product safety and release, but the methods don’t always cooperate. Inhibitory formulations, antimicrobial preservatives, complex matrices, and low sample volumes can all compromise recovery and produce results that are technically compliant but scientifically questionable.
We approach bioburden enumeration as a method design problem, not just a testing service. Before any sample is plated, we evaluate the product matrix, assess potential for inhibition, and select or develop an approach that actually recovers organisms under realistic conditions. That groundwork is what makes the data defensible.
What We Test
We support enumeration or bioburden programs across a wide range of product types and program contexts:
Drug products: oral solids, liquids, semi-solids, topicals, inhalation products, and products with preservative systems
Medical devices: device extractions, fluid path testing, and finished device bioburden
Raw materials and components: excipients, APIs, packaging components, elastomers, and materials of construction
Whether you’re running routine release testing, supporting a stability program, or qualifying a new method, we structure the program around your regulatory context and timeline.
Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) (or Bioburden)
USP <61> establishes the compendial methods for quantitative bioburden enumeration of aerobic microorganisms and fungi. TAMC and TYMC are the standard outputs, reported in CFU per gram or per mL, and form the basis of microbial limits testing for non-sterile products across USP and EP frameworks.
Accurate results require more than following the method. Recovery depends on proper neutralization of antimicrobial activity, appropriate diluent selection, and media and incubation conditions suited to the product. When these details aren’t right, counts are suppressed and limits that should fail may appear to pass.
We don’t treat method suitability as a formality. It’s where the real method development happens.
Method Suitability
USP <61> requires demonstration that the test method recovers the specified challenge organisms at acceptable levels — a confirmation that the product matrix is not interfering with the assay. This is called method suitability, and it’s required before any enumeration results can be considered valid.
For straightforward products, suitability is routine. For inhibitory or antimicrobial products, it requires troubleshooting: neutralizer screening, dilution optimization, filtration approaches, and sometimes method modification. We have direct experience with products that have failed suitability repeatedly elsewhere and required a different technical strategy to resolve.
Method suitability studies are offered as standalone engagements or as the first phase of an ongoing testing program.
Specified Organism Testing: USP <62> and USP <60>
Beyond total counts, certain organisms must be specifically detected or absent depending on the product type, route of administration, and regulatory classification. USP <62> defines the specified organisms relevant to non-sterile pharmaceutical products and the qualitative methods used to detect them.
Commonly tested specified organisms include:
- Escherichia coli
- Salmonella species
- Pseudomonas aeruginosa
- Staphylococcus aureus
- Clostridia
- Bile-tolerant gram-negative bacteria
Burkholderia Cepacia Complex: USP <60>
Burkholderia cepacia complex (BCC) requires its own dedicated method under USP <60>, and for good reason. BCC is an intrinsically antibiotic-resistant, opportunistic pathogen of particular concern in aqueous non-sterile products, oral liquids, nasal sprays, and other formulations used by immunocompromised patients.
Standard detection media used in USP <62> are not selective enough for reliable BCC detection. USP <60> addresses this with a specific enrichment and selective plating approach designed to detect BCC even at low levels and in the presence of competitive flora.
We perform BCC testing as a standalone service and as part of broader specified organism programs. Given the regulatory attention this organism has received (including FDA warning letters and product recalls) we recommend treating BCC testing as a non-negotiable component of any aqueous non-sterile product’s microbial limits program.
Program Design
Enumeration testing doesn’t exist in isolation. We help clients think through the full program structure:
Frequency and sampling strategy: how many samples, at what intervals, and from which points in the process or supply chain
Specification alignment: ensuring microbial limits are appropriate for the product type, route of administration, and applicable pharmacopeial category
Documentation and data package : results reported with full traceability, method suitability data on file, and formatted for regulatory submission or audit review
Investigation support: when results are out of specification or trending, we support root cause analysis and retesting strategies
Standards and Regulatory Framework
Our enumeration programs are performed in alignment with:
- USP <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests
- USP <62> Microbiological Examination of Nonsterile Products: Tests for Specified Microorganisms
- USP <60> Microbiological Examination of Nonsterile Products: Burkholderia cepacia
- European Pharmacopoeia (EP) 2.6.12 / 2.6.13 equivalent methods
- FDA cGMP expectations under 21 CFR 211
Ready to talk through your enumeration program?
Whether you’re establishing a new testing program, troubleshooting a method suitability failure, or looking to outsource routine release testing, we’re built for programs that require more than a standard approach.
